comparemela.com

Latest Breaking News On - Poster discussions - Page 1 : comparemela.com

ImmVira presented latest encouraging clinical results of two proprietary products at ASCO 2023

/PRNewswire/ ImmVira submitted four abstracts covering latest results from Phase I/II clinical trials of MVR-T3011 IT (intratumoral injection) and MVR-T3011.

United statesAmerican society for clinical oncology annual meetingClinical oncology annual meetingPoster discussionsCommon criteriaAdverse eventsSerious adverse eventOncolytic virusCancer vaccineBiosynthetic exosome

Antengene To Present Latest Results from TORCH-2 Study of ATG-008 in Advanced Solid Tumors in Poster Discussion at ASCO 2023

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to.

South koreaUnited statesMccormick placeHong kongPeter qianAsia pacificHong kong stock exchangePrnewswire antengene corporation limitedCompany annualEastern cooperative oncology groupAntengene corporation limitedAmerican society for clinical oncology annual meetingAntengene corporationMccormick place convention centerCorporation limitedClinical oncology annual meeting

vimarsana © 2020. All Rights Reserved.